AUTH/3758/4/23 - Complainant v ALK-Abelló

Alleged promotion of Jext on Facebook and conduct of a representative

  • Received
    04 April 2023
  • Case number
  • Applicable Code year
  • Completed
    10 May 2024
  • Breach Clause(s)
  • Sanctions applied
    Undertaking received
  • Additional sanctions
  • Appeal
    No appeal

Case Summary

This case related to an ALK-Abelló representative’s Facebook status which made reference to the company’s prescription only medicine Jext (adrenaline tartrate) and contained a link to the Jext website.

The outcome under the 2021 Code was:

Breach of Clause 5.1

Failing to maintain high standards

Breach of Clause 17.2

Representative failing to maintain a high standard of ethical conduct

Breach of Clause 26.1

Promoting a prescription only medicine to the public

This summary is not intended to be read in isolation.
For full details, please see the full case report below.